| 注册
首页|期刊导航|中国临床药理学杂志|瑞舒伐他汀联合普罗布考对急性冠状动脉综合征患者血清超敏C反应蛋白及血脂的影响

瑞舒伐他汀联合普罗布考对急性冠状动脉综合征患者血清超敏C反应蛋白及血脂的影响

李荣霏 易高众 刘志华

中国临床药理学杂志2012,Vol.28Issue(10):737-739,3.
中国临床药理学杂志2012,Vol.28Issue(10):737-739,3.

瑞舒伐他汀联合普罗布考对急性冠状动脉综合征患者血清超敏C反应蛋白及血脂的影响

Effect of rosuvastatin combination with probucol on the level of serum high-sentivity C-reactive protein and lipids in patients with acute coronary syndrome

李荣霏 1易高众 2刘志华1

作者信息

  • 1. 怀化医学高等专科学校药理学教研室,湖南怀化418000
  • 2. 怀化市第一人民医院,湖南怀化418000
  • 折叠

摘要

Abstract

Objective To explore the effect of rosuvastatin and probucol combination on the level of serum high - sentivity C - reactive protein and lipids in acute coronary syndrome ( ACS). Methods Sixty - five ACS -patients were randomly assigned to three groups; rosuvastatin group(10 mg ? D-1) , probucol group(0. 5 g,bid) ,rosuvastatin(10 mg ? D-1) and probucol combined group(0.5 g,bid). All patients were followed up for 8 weeks. Serum level of high sensitivity C - reactive protein ( hs - CRP) , total cholesterol (TC) , triglyceride(TG) , low density lipoprotein cholesterol (LDL - C) and high density lipoprotein cholesterol( HDL - C) were measured before and after treatment. Results After 8 weeks treatments, the levels of hs - CRP, TC and LDL - C in three groups compared with before treatment decreased significantly, compared with the single used groups, the combination group decreased significantly ( P < 0. 05 or P < 0.01). Conclusion The combined treatment with rosuvastatin and probucol yielded better results in lowing the level of hs - CRP and cholesterol in ACS patients.

关键词

急性冠状动脉综合征/瑞舒伐他汀/普罗布考/超敏C反应蛋白

Key words

acute coronary syndrom/rosuvastatin/ probucol/ high sensitive C - reactive protein

分类

医药卫生

引用本文复制引用

李荣霏,易高众,刘志华..瑞舒伐他汀联合普罗布考对急性冠状动脉综合征患者血清超敏C反应蛋白及血脂的影响[J].中国临床药理学杂志,2012,28(10):737-739,3.

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文